Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,575 | 1 | 61.6% |
| Travel and Lodging | $1,864 | 3 | 32.1% |
| Food and Beverage | $362.40 | 5 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $5,689 | 8 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $112.34 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $5,689 | 8 | Insmed, Inc. ($5,689) |
| 2018 | $112.34 | 1 | Merck Sharp & Dohme Corporation ($112.34) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2019 | Insmed, Inc. | Arikayce (Drug) | Consulting Fee | Cash or cash equivalent | $3,575.00 | General |
| Category: Respiratory | ||||||
| 09/30/2019 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | Cash or cash equivalent | $1,367.19 | General |
| Category: Respiratory | ||||||
| 09/30/2019 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | Cash or cash equivalent | $282.83 | General |
| Category: Respiratory | ||||||
| 09/30/2019 | Insmed, Inc. | Arikayce (Drug) | Travel and Lodging | Cash or cash equivalent | $213.57 | General |
| Category: Respiratory | ||||||
| 09/30/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | Cash or cash equivalent | $143.61 | General |
| Category: Respiratory | ||||||
| 09/30/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | Cash or cash equivalent | $45.67 | General |
| Category: Respiratory | ||||||
| 09/30/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | Cash or cash equivalent | $39.40 | General |
| Category: Respiratory | ||||||
| 09/30/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| Category: Respiratory | ||||||
| 01/25/2018 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological) | Food and Beverage | In-kind items and services | $112.34 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 464 | 582 | $302,864 | $57,816 |
| 2022 | 8 | 463 | 663 | $352,050 | $64,882 |
| 2021 | 7 | 380 | 568 | $80,555 | $54,540 |
| 2020 | 7 | 370 | 650 | $92,630 | $59,730 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 99 | 101 | $88,577 | $14,178 | 16.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 71 | 109 | $49,268 | $10,501 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 97 | $43,650 | $9,196 | 21.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 83 | 139 | $43,646 | $8,797 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 52 | $31,408 | $6,517 | 20.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 34 | $21,240 | $3,557 | 16.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $17,675 | $3,341 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $7,400 | $1,727 | 23.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 136 | 147 | $128,267 | $22,353 | 17.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 123 | 263 | $117,195 | $21,488 | 18.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 75 | 106 | $33,284 | $6,038 | 18.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 44 | $26,576 | $5,952 | 22.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 44 | 46 | $27,600 | $5,004 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 28 | $12,600 | $2,720 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $3,552 | $796.53 | 22.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 17 | $2,975 | $529.90 | 17.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 109 | 226 | $25,511 | $18,479 | 72.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 93 | 96 | $22,012 | $15,136 | 68.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 68 | 130 | $13,736 | $6,731 | 49.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 45 | 45 | $6,164 | $4,790 | 77.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 29 | 35 | $6,775 | $4,577 | 67.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $4,023 | $3,209 | 79.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 18 | $2,335 | $1,618 | 69.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 132 | 372 | $50,056 | $29,794 | 59.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 66 | 69 | $15,556 | $11,127 | 71.5% |
About Dr. Lisa Brumble, MD
Dr. Lisa Brumble, MD is a Infectious Disease healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1669461398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Brumble, MD has received a total of $5,801 in payments from pharmaceutical and medical device companies, with $5,689 received in 2019. These payments were reported across 9 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($3,575).
As a Medicare-enrolled provider, Brumble has provided services to 1,677 Medicare beneficiaries, totaling 2,463 services with total Medicare billing of $236,968. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Jacksonville, FL
- Active Since 10/15/2005
- Last Updated 08/31/2020
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1669461398
Products in Payments
- Arikayce (Drug) $5,689
- ZINPLAVA (Biological) $112.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Jacksonville
Dr. Pablo Pella, Md, MD
Infectious Disease — Payments: $139,265
Daniela Chiriboga-Salazar, M.d, M.D
Infectious Disease — Payments: $77,648
Mohammed Reza, Md, MD
Infectious Disease — Payments: $56,351
Robert Catalla, Md, MD
Infectious Disease — Payments: $48,830
Shalika Katugaha, Md, MD
Infectious Disease — Payments: $40,883
Ivan Guerrero, Md, MD
Infectious Disease — Payments: $26,872